Clinical Trials Browser

Non-Small Cell Lung Cancer Metastatic × 90 days × Clear all

NCT04163432 2026-05-19

STAGGER

Phase 2 Active not recruiting

43 enrolled 12 charts

Non-Small Cell Lung Cancer Metastatic

NCT04619004 2026-05-14

HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer

Phase 2 Active not recruiting

277 enrolled 16 charts

Non-Small Cell Lung Cancer Metastatic